Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 11, 2013, Pages 1407-1413

  Barcroft, J ^a   Dayoub, N ^a   Thong, K J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; Cryopreservation; Embryo; Fertility Preservation; IVF

Indexed keywords

BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; NAFARELIN; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CRYOPRESERVATION; CUTANEOUS T CELL LYMPHOMA; EMBRYO; EMBRYO CRYOPRESERVATION; ENDOMETRIAL THICKNESS; ENDOMETRIUM CARCINOMA; ESTROGEN THERAPY; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW UP; FREEZE THAWING; HODGKIN DISEASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; NONHODGKIN LYMPHOMA; OOCYTE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SARCOMA; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

ADULT; CRYOPRESERVATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; EMBRYO, MAMMALIAN; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84890566693     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0024-z     Document Type: Article

References (32)

1. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a cochrane review. Hum Reprod. 2002;17:874-85.
2. Al-Inany HG, Youssef MAFM, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum Reprod Update. 2011;17:435.
3. Azim Jr HA, Peccatori FA, de Azambuja E, Piccart MJ. Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticanc. 2011;11:287-98.
4. Baynosa J, Westphal LM, Madrigrano A, Wapnir I. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009;209:603-7.
5. Berger BM, Ezcurra D, Alper MM. Gonadotropin releasing hormone (GnRH) antagonist (cetrorelix) versus GnRH agonist treatment - an age and gonadotropin matched study in young normal responders. Fertil Steril. 2004;82:S235-6.
6. Besse D, Bellavia M, de Ziegler D and Wunder D. Psychological support in young women who contemplate emergency assisted reproductive technologies (ART) prior to chemo- and/or radiation-therapy. Swiss Med Wkly. 2010;140.
7. Brzyski RG. Efficacy of postal communication with patients who have cryopreserved pre-embryos. Fertil Steril. 1998;70:949-51.
8. Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remohí J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89(6):1657-64.
9. Das M, Shehata F, Moria A, Holzer H, Son W-Y, Tulandi T. Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy. Fertil Steril. 2011;96:122-5.
10. De Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD. Pregnancy after breast cancer. A comprehensive review. J Surg Oncol. 2010;101:534-42.
11. Duffy CM, Allen SM, Clark MA. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol. 2005;23:766-73.
12. Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling vs vitrification) of human oocytes and embryos. Hum Reprod Update. 2012;in press.
13. Fasouliotis SJ, Schenker JG. Cryopreservation of embryos: medical, ethical, and legal issues. J Assist Reprod Gen. 1996;13:756-61.
14. Forbes JF. Long-term effects of adjuvant chemotherapy in breast-cancer. Acta Oncol. 1992;31:243-50.
15. Forman EJ, Anders CK, Behera MA. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. 2009;54(4):203-7.
16. Hery C, Ferlay J, Boniol M, Autier P. Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Ann Oncol. 2008;19:1009-18.
17. Holleb AI. Breast cancer and pregnancy. CA Cancer J Clin. 1965;15:182-3.
18. Janerich DT. The fetal antigen hypothesis: cancers and beyond. Med Hypotheses. 2001;56:101-3.
19. Kini S, Li HWR, Morrell D, Pickering S, Thong KJ. Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization. J Assist Reprod Gen. 2010;27:449-56.
20. Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24:4888-94.
21. Lee S, Oktay K. Does higher starting dose of FSH stimulation with letrozole improve fertility cryopreservation outcomes in women with breast cancer? Fert Steril. 2012;98(4):961-4.
22. Nachtigall RD, Mac Dougall K, Lee M, Harrington J, Becker G. What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition. Fertil Steril. 2010;94:2069-72.
23. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Elsner CW, Mitchell-Leef D, et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil Steril. 2009;92(2):520-6.
24. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347-53.
25. Provoost V, Pennings G, De Sutter P, Gerris J, Van de Velde A, Dhont M. To continue or discontinue storage of cryopreserved embryos? Patients' decisions in view of their child wish. Hum Reprod. 2011;26:861-72.
26. Riggs R, Mayer J, Dowling-Lacey D, Chi T-F, Jones E, Oehninger S. Does storage time influence postthaw survival and pregnancy outcome? An analysis of 11,768 cryopreserved human embryos. Fertil Steril. 2010;93:109-15.
27. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril. 2011;95:588-91.
28. Sonmezer M, Turkcuoglu I, Coskun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.
29. Stadtmauer LA, Duran H, Bocca S, Oehninger S. A comparison between gonadotropin releasing hormone (GNRH) agonist and antagonist protocols in women with good ovarian reserve undergoing IVF. Fertil Steril. 2006;86:S437.
30. Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update. 2009;15:587-97.
31. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354:1586-90.
32. Yang D, Brown SE, Nguyen K, Reddy V, Brubaker C, Winslow KL. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertil Steril. 2007;87(6):1469.